US › Healthcare

Invivyd Inc. (IVVD)

US · Healthcare · Biotechnology

$0.57+3.92%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$13.7M
Revenue YoY
+21.6%
Net profit
$-41.4M
Profit YoY
-154.2%
EPS
$-0.13
EPS estimate
$-0.08
Net margin
-301.2%

EPS came in at -0.13 against a street estimate of -0.08 — a miss of 62.5%.

Key statistics

Market cap
$162.5M
Forward P/E
44.6
P/B
0.77
Book value
$0.72
EPS (TTM)
$-0.29
52-week high
$3.07
52-week low
$0.48
50-day MA
$0.88
200-day MA
$1.62
Beta
0.71

Analyst view

Analysts rate Invivyd Inc. a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $10.00.

Shareholding

Insiders
7.07%
Institutions
84.60%

Largest institutional holders

FundStake
HHG PLC11.23%
Perceptive Advisors LLC7.08%
Bvf Inc6.63%
Maverick Capital Ltd6.44%
Saturn V Capital Management LLC3.72%
Vanguard Group Inc3.63%
Vanguard Capital Management, LLC3.42%
M28 Capital Management LP3.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Invivyd Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.